Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

Science advances·2026

Same author

RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1.

PloS one·2026

Same author

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations.

EMBO molecular medicine·2025

Same author

Systemic <i>Kras</i> ablation disrupts myeloid cell homeostasis in adult mice.

Proceedings of the National Academy of Sciences of the United States of America·2025

Search research articles

Related Experiment Video

Updated: Mar 10, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

Modeling RASopathies with Genetically Modified Mouse Models.

Isabel Hernández-Porras¹, Carmen Guerra²

¹Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain.

Methods in Molecular Biology (Clifton, N.J.)

|December 8, 2016

Summary

This summary is machine-generated.

RASopathies are developmental syndromes caused by RAS/MAPK pathway mutations. Genetically modified mouse models are crucial for understanding these conditions and developing new therapies for related abnormalities.

Keywords:

Knockin Knockout MAPK signaling developmental disorders Mouse models RAS signaling RASopathies Rare diseases

More Related Videos

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Published on: July 18, 2019

Related Experiment Videos

Last Updated: Mar 10, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Published on: July 18, 2019

Area of Science:

Genetics
Developmental Biology
Oncology

Background:

The RAS/MAPK signaling pathway is vital for cellular functions and implicated in cancer.
RASopathies are a group of developmental syndromes arising from germline mutations in this pathway.
These syndromes share common molecular underpinnings but present diverse clinical phenotypes.

Purpose of the Study:

To review genetically modified mouse models used in RASopathies research.
To highlight the utility of these models in understanding disease mechanisms and phenotypes.
To explore the potential of novel technologies in advancing RASopathies research.

Main Methods:

Review of genetically modified mouse models relevant to RASopathies.
Analysis of how these models elucidate molecular and cellular bases of RASopathies.
Discussion of the application of these models in studying tumor predisposition and therapeutic strategies.

Main Results:

Genetically modified animal models, particularly mice, have been instrumental in understanding RASopathies.
These models allow for the investigation of genotype-phenotype correlations and the impact of genetic background.
They serve as platforms for evaluating preventative and therapeutic interventions.

Conclusions:

Genetically modified mouse models are essential tools for RASopathies research.
These models facilitate the study of complex phenotypes, cancer predisposition, and treatment strategies.
Future research incorporating novel technologies promises to resolve outstanding questions in the field.